ZW

Zheng Wang

CC Chia Tai Tianqing Pharmaceutical Group Co.: 2 patents #20 of 95Top 25%
SC Shandong Danhong Pharmaceutical Co.: 2 patents #1 of 15Top 7%
SC Shanghai Haiyan Pharmaceutical Technology Co.: 2 patents #3 of 33Top 10%
YC Yangtze River Pharmaceutical Group Co.: 2 patents #3 of 33Top 10%
CO Conopco: 1 patents #46 of 208Top 25%
📍 Shanghai, VA: #5 of 12 inventorsTop 45%
Overall (2020): #12,353 of 565,922Top 3%
8
Patents 2020

Issued Patents 2020

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
10874674 Crystal form of orexin receptor antagonist compound, and preparation method and application thereof Songliang Wu, Zhi Luo, Yuan Chen, Yuhe Wang, Dakun Qin +3 more 2020-12-29
10858322 Process for preparing 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[D]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one Weihua Shi, Feng Xu, Weidong Li, Linghui Wu, Hongwei Li +4 more 2020-12-08
10780091 TLR7 agonist maleate salt, crystalline forms C, D and E thereof, preparation methods and uses of maleate salt and crystalline forms Zhaozhong Ding, Fei Sun, Yinghu Hu, Yilong Zhou, Ling Yang 2020-09-22
10745367 Method for preparing formamide compound Kuiling Ding, Lei Zhang, Zhaobin Han, Xiaoyu ZHAO 2020-08-18
10709652 Skin care composition Bingqing Wang, Qian Zhang, Xia Zheng 2020-07-14
10683296 TLR7 agonist trifluoroacetate salt and crystalline form B thereof, preparation methods and uses Zhaozhong Ding, Fei Sun, Yinghu Hu, Yilong Zhou, Rui Zhao +1 more 2020-06-16
10668066 Crystal form of orexin receptor antagonist compound, and preparation method and application thereof Songliang Wu, Zhi Luo, Yuan Chen, Yuhe Wang, Dakun Qin +3 more 2020-06-02
10633347 Crystal form B of 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[d]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one Weihua Shi, Feng Xu, Weidong Li, Linghui Wu, Hongwei Li +4 more 2020-04-28